.

.


LogOff Samples
The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 16 Issue 5 Pages: 563-74
    Pub: 1985 Nov Epub:
    • Kumada T
    • Neu HC

  2. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Anaerobe (Anaerobe ) Vol: 43 Issue Pages: 69-74
    Pub: 2017 Feb Epub: 2016 Nov 25
    • Tan TY
    • Ng LS
    • Kwang LL
    • Rao S
    • Eng LC

  3. Rifaximin modulates the colonic microbiota of patients with Crohn`s disease: an in vitro approach using a continuous culture colonic model system.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 65 Issue 12 Pages: 2556-65
    Pub: 2010 Dec Epub: 2010 Sep 18
    • Maccaferri S
    • Vitali B
    • Klinder A
    • Kolida S
    • Ndagijimana M
    • Laghi L
    • Calanni F
    • Brigidi P
    • Gibson GR
    • Costabile A

  4. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Enfermedades infecciosas y microbiologia clinica (Enferm Infecc Microbiol Clin ) Vol: 9 Issue 4 Pages: 219-22
    Pub: 1991 Apr Epub:
    • Alados JC
    • Martínez-Brocal A
    • Miranda C
    • Rojo MD
    • García V
    • Domínguez MC
    • de la Rosa M

  5. Curated database of commensal, symbiotic and pathogenic microbiota
    Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages:
    Pub: 2014 Jun Epub:
    • D'Adamo Peter

  6. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach
    Clinical and Experimental Gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 309-325
    Pub: 2015 Dec 4 Epub: 2015 Dec 4
    • Soldi S
    • Vasileiadis S
    • Uggeri F
    • Campanale M
    • Morelli L
    • Fogli MV
    • Calanni F
    • Grimaldi M
    • Gasbarrini A

  7. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    The Japanese journal of antibiotics (Jpn J Antibiot ) Vol: 51 Issue 7 Pages: 437-74
    Pub: 1998 Jul Epub:
    • Ikemoto H
    • Watanabe K
    • Mori T
    • Igari J
    • Oguri T
    • Shimizu Y
    • Terai T
    • Inoue H
    • Nakadate T
    • Ito C
    • Yoshida T
    • Ohno I
    • Tanno Y
    • Arakawa M
    • Igarashi K
    • Okada M
    • Ozaki K
    • Aoki N
    • Kitamura N
    • Sekine O
    • Suzuki Y
    • Nakata K
    • Nakatani T
    • Inagawa H
    • Kusano N

  8. Doxycycline induces dysbiosis in female C57BL/6NCrl mice
    BMC Research Notes (BMC Res Notes ) Vol: 10 Issue Pages: 644
    Pub: 2017 Nov 29 Epub: 2017 Nov 29
    • Boynton FD
    • Ericsson AC
    • Uchihashi M
    • Dunbar ML
    • Wilkinson JE

  9. Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections.
    Diagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis ) Vol: 43 Issue 1 Pages: 49-60
    Pub: 2002 May Epub:
    • Johnson DM
    • Biedenbach DJ
    • Jones RN

  10. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 17 Issue 2 Pages: 273-9
    Pub: 1980 Feb Epub:
    • Hall WH
    • Opfer BJ
    • Gerding DN

Full list available by paid subscriptions

For More information see this summary.